A Critical Review of Icosapent Ethyl in Cardiovascular Risk Reduction
This article aims to provide a critical review of the clinical data available regarding cardiovascular benefits of IPE in patients with ASCVD and its value as a treatment option for patients with elevated TG levels.
Source: American Journal of Cardiovascular Drugs - Category: Cardiology Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | Fish | Fish Oil | Food and Drug Administration (FDA) | Heart | Statin Therapy | Study